Stay updated with breaking news from Genomic Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MONDAY, July 18, 2022 (HealthDay News) -- A drug in development as a cancer therapy may also help the body regenerate damaged nerves after spinal injuries, new research suggests.
Scientists have shown that a brain-penetrating candidate drug can foster the regeneration of damaged nerves after spinal trauma.
The Office of Cancer Clinical Proteomics Research at the National Cancer Institute has awarded $4.2 million over five years to Mount Sinai researchers establishing a Proteogenomic Data Analysis Center to advance cancer research and treatments.
July 12, 2022: Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of damaged nerves after spinal trauma. The research, published today in Clinical and Translational Medicine, used...
Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of damaged nerves after spinal trauma